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Transurethral procedures are frequently used in geri-
atric subjects. Patients in this age group may experience
accompanying health problems such as atheroscle-
rotic cardiovascular diseases, chronic obstructive lung
disease, renal function disorders, hypertension, or dia-
betes mellitus. Therefore, the choice of anesthetic
method is crucial in transurethral procedures. Priority
should be given to the use of an anesthetic method
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The aim of this study was to compare spinal, low-dose spinal, and epidural anesthesia using
ropivacaine and fentanyl combinations for transurethral surgical procedures. Sixty patients with
American Society of Anesthesiologists scores of I–III were allocated into three groups. After pre-
loading with 5 mL/kg normal saline, patients in the spinal anesthesia group (Group S) received
15 mg of hyperbaric ropivacaine plus 25 μg of fentanyl intrathecally; patients in the epidural
anesthesia group (Group E) received 112.5 mg of ropivacaine plus 25 μg of fentanyl epidurally via
an epidural catheter; and patients in the low-dose spinal anesthesia group (Group L) received
10 mg of hyperbaric ropivacaine plus 25 μg of fentanyl intrathecally. Blood pressure, heart rate,
peripheral oxygen saturation, time to onset of thoracic (T)-10 dermatome, two-segment sensorial
block regression time, full recovery of sensorial block, maximum motor blockade levels, motor
blockade regression time, additional analgesic administration, patient comfort, and complica-
tions were recorded. The time to the onset of T10 dermatome level was shortest in Group S and
longest in Group E (p < 0.001). The sensorial blockade time and motor blockade regression time
were shorted in Group L (p < 0.001). The two-segment sensorial block regression time in Group E
exceeded that in the other groups. Additional analgesic administration was not needed in any
group. No complications or adverse effects were observed in any patient. We conclude that all
three anesthetic techniques may be used safely and are appropriate for transurethral surgical pro-
cedures. However, low-dose spinal anesthesia with ropivacaine plus fentanyl may be preferable
in transurethral surgery because we reach an adequate sensorial level with less motor blockade.
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that has the least effect on cardiovascular stability
and hemodynamics [1].
Regional anesthetic methods are commonly pre-
ferred in transurethral procedures because of their ad-
vantages such as less postoperative pain, less nausea
and vomiting, early patient mobilization, and shorter
hospital stay. This technique can be performed with
the use of local anesthetics alone in different doses
and intensity, or by combining local anesthetics with
adjuncts such as opioids to obtain an adequate level
of anesthesia together with more stable hemodynam-
ics [2]. Bupivacaine is commonly used in spinal anes-
thesia. However, its prolonged effects may lead to a
delay in motor block resolution, urinary retention, and
a prolonged hospital stay. These problems limit the
use of bupivacaine in day-case settings [3]. Alterna-
tively, agents with a short effect such as lidocaine are
associated with transient neurological symptoms [4].
Therefore, the search continues for a local anesthetic
that offers a low motor blockade rate and short term
effects, but without transient neurological symptoms.
Ropivacaine is a local anesthetic with similar effects
and a greater safety margin than bupivacaine [5–7].
Intrathecal ropivacaine has been shown to cause equal
sensory block, less motor block, and rapid regression of
sensory block than bupivacaine at similar doses [8].
However, very few studies have evaluated the effect of
ropivacaine and fentanyl at different doses during epi-
dural and spinal anesthesia in transurethral procedures.
In this prospective randomized study, we compared
the anesthesia quality, patient comfort, and complica-
tions between three groups of patients who underwent
a transurethral procedure. The first two groups re-
ceived a standard (15mg; Group S) or low dose (10mg;
Group L) of hyperbaric ropivacaine plus 25 μg of fen-
tanyl by spinal anesthesia, and a third group received
an epidural combination of 15 mL of 7.5 mg/mL ropi-
vacaine plus 25 μg of fentanyl (Group E).
MATERIAL AND METHODS
Patients
This prospective randomized study protocol was ap-
proved by the Local Ethics Committee of Pamukkale
University, Medical Faculty Hospital, and written in-
formed consent was obtained from each patient. We
randomly selected a total of 60 patients with American
Society of Anesthesiologists scores of I–III. The patients
weighed 60–100 kg, were more than 1.60 m tall, and
were scheduled for transurethral surgical procedures
[e.g. transurethral resection of the prostate (TUR-P)
and transurethral resection of bladder tumors]. Pa-
tients with serious central nervous system or periph-
eral nervous system disorders, organ failure, severe
anemia, shock, severe systemic infection or infection
at the injection site, coagulation defects, history of al-
lergy to any type of local anesthetics, and syndromes
precluding intrathecal drug administration (e.g. ky-
phosis, scoliosis, and previous operations) were ex-
cluded from the study. We did not include patients
who did not volunteer for the technique. The patients
were allocated into three groups using a random
samples table (20 patients/group).
Anesthesia and operation procedure
In the operating room, all patients were administered
oxygen at 2–4 L/min via a nasal cannula. Electrocar-
diography, non-invasive arterial blood pressure (BP),
heart rate (HR), peripheral oxygen saturation (SpO2)
and respiration rate (RR) were monitored and re-
corded. An 18-G cannula was used for peripheral intra-
venous access, and 0.9% NaCl solution (5 mL/kg) was
preloaded. Throughout the procedure, 0.9% NaCl in-
fusion was maintained at a rate of 6 mL/kg/hr.
Hyperbaric ropivacaine solution was prepared by
adding 2 mL of 20% dextrose to 4 mL of 7.5 mg/mL
ropivacaine solution (0.75%; Naropin®; Astra Zeneca,
Södertälje, Sweden); the final concentration of hyper-
baric ropivacaine was 5 mg/mL. All three regional
anesthesia techniques were applied to the patients in
the right lateral position.
After skin antisepsis procedures in the Group S and
Group L, a 25-G Quinke needle (Spinocan, Braun
Melsungen AG, Melsungen, Germany) was advanced
from the lumbar (L) L2–L3 or L3–L4 interspinous space,
parallel to the dura fibers. Once cerebrospinal fluid
appeared in the needle, the needle tip was rotated to
the cephalad direction. If the cerebrospinal fluid re-
mained clear, it was confirmed that the tip of the needle
was completely placed in the subarachnoid cavity. In
Group S, 15 mg of hyperbaric ropivacaine and 25 μg of
fentanyl citrate (50 μg/mL; Abbott Labs, Chicago, IL,
USA) were injected intrathecally within 30 seconds. In
Group L, 10 mg of hyperbaric ropivacaine and 25 μg of
fentanyl were injected intrathecally within 30 seconds.
In Group E, after the skin antisepsis, 0.1–0.2 mL of
prilocaine was injected subcutaneously at the planned
injection site. To identify the epidural space, we used
the loss of resistance technique by administering sa-
line via an 18-G Tuohy needle at L2–L3 or L3–L4. The
epidural catheter (Perifix®, Braun, Melsungen AG,
Melsungen, Germany) was advanced by 3–4 cm and
inserted into the epidural space. The catheter was fixed
from the waist and back to the shoulders. The patient
was then placed into the supine position and the test
dose of 3 mL of 2% lidocaine was infused from the tip
of the catheter over 3 minutes. Once the epidural space
was confirmed, 15 mL of 7.5 mg/mL ropivacaine and
25 μg of fentanyl were injected epidurally within 
30 seconds.
After the injection, the patients in all groups were
quickly placed into the supine position. The sensory
anesthesia level was assessed on the midclavicular
line with the bilateral pinprick test using a 27-G blunt
needle. The time to onset of analgesia was defined as
the time to the onset of sensory block at any spinal
segment level. The motor block level was assessed
using the modified Bromage scale (0 = no motor block,
the patient is able to partially bend knees while lying
supine; 1 = partial motor blockade, the patient is able
to move knees; 2 = almost complete motor blockade,
the patient is able only to move feet; and 3 = complete
motor blockade, inability to flex ankle joints). The
time to onset time of thoracic (T)-10 dermatome, sen-
sorial block two-segment regression time, time to full
recovery from sensorial block, highest motor block-
ade levels, and motor blockade regression time were
recorded.
Mean arterial BP, HR, and SpO2 values were
measured by an anesthesia monitor (ADU Cardiocap
5, Datex Ohmeda, Helsinki, Finland). Requirement
for additional analgesia and adverse effects such as
nausea, vomiting, and itching were also recorded.
Patient comfort was assessed using a four-point scale
(1 = very good, no discomfort; 2 = good, weak discom-
fort, no opioid requirement; 3 = middle, pain present,
opioids required; 4 = insufficient, severe pain, general
anesthesia required).
Intraoperative hypotension was defined as a 20%
decrease from baseline or a systolic BP < 90 mmHg. 
In the event of intraoperative hypotension, 5 mg of
ephedrine HCl (Biosel, Istanbul, Turkey) was admin-
istered intravenously. Furthermore, 0.5 mg of atropine
sulfate (Haver, Istanbul, Turkey) was administered
intravenously if HR fell below 55 beats/min. The total
amount of ephedrine and atropine used was recorded.
A RR of < 10 breaths/min and SpO2 < 92% were con-
sidered to indicate respiratory depression.
Sufficiency of surgical anesthesia, the patient’s sub-
jective response to surgery, the need for additional
analgesics or general anesthesia were recorded. If
sufficient anesthesia could not be obtained, 50 mg of
meperidine was administered intravenously. General
anesthesia was used if the patient had repeated com-
plaints of pain.
Post operation, patients with a modified Aldrete
score of 9 were taken to their respective wards. Be-
cause a Foley catheter was inserted at this time, the
development of urine retention could not be assessed.
Statistical analysis
All data were analyzed using SPSS version 10.0 (SPSS
Inc. Chicago, IL. USA). One-way analysis of variance
(ANOVA) was used to assess the following: demo-
graphic data, duration of operation, time to reach the
T-10 dermatome, time to reach maximum sensory
level, sensorial block two-segment regression time,
motor block regression time, time to full recovery
from sensorial block, maximum motor block level,
amount of ephedrine used, and the first dose of anal-
gesic needed. Tukey’s post hoc test was used to iden-
tify differences between groups for parameters that
were found to be significant with ANOVA (p < 0.05).
Repeated-measures ANOVA was used to assess pre-
operative and postoperative mean BPs and HR. Data
are reported as mean ± standard deviation. Side ef-
fects such as nausea, vomiting, itching, local anes-
thetic agent toxicity findings, and patient comfort were
assessed with Pearson’s χ2 test. A value of p < 0.05
was considered statistically significant.
RESULTS
Demographic characteristics
The demographic characteristics were similar for all
groups, with no statistical differences between the
groups in terms of age, height, weight, American
Society of Anesthesiologists physical condition, and
the transurethral procedures performed (Table 1).
Characteristics of the operation and
anesthesia
No significant difference was found between the three
groups with respect to the operation times. There was
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a significant difference between Groups S and E (p <
0.001), Groups S and L (p < 0.05) and Groups E and L
(p<0.001) for the time to reach maximum sensory level.
In addition, the time to reach the T-10 dermatome level
was significantly different between Groups S and E,
Groups E and L, and Groups S and L (all: p < 0.001;
Table 2). The time to full recovery from sensorial block
was similar in Groups S and E, but shorter in Group
L than in Groups S and E (both: p < 0.001). No signifi-
cant difference was observed between Groups S and
E for motor block regression time. The motor block
regression time in Group L was significantly shorter
than that in Groups S and E (both: p<0.001). There was
a statistically significant difference between the two-
segment regression times (p < 0.001) and was signi-
ficantly longer in Group E than in Groups S and L
(both: p < 0.001).
At minute 3, a block was obtained at T12 (thoracic
12th vertebral level spinal anesthesia) more quickly in
Group S than in Groups E and L (p < 0.05). None of
the groups showed a block at T7, but the desired block
at T10 was reached in all groups (Figure 1).
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Table 1. Characteristics of the 60 patients with different transurethral procedures*
Group S (n = 20) Group L (n = 20) Group E (n = 20) p
Age (yr) 69.0 ± 3.2 71.0 ± 2.6 70.0 ± 4.9 0.2
Weight (kg) 73.5 ± 6.8 73.0 ± 6.5 76.05 ± 11.9 0.5
Height (cm) 172.6 ± 4.1 172.8 ± 3.1 167.8 ± 12.7 0.1
ASA I/II/III (n) 1/19/0 1/15/4 5/13/2 0.2
Duration of surgery (min) 122.8 ± 3.4 122.7 ± 4.4 122.8 ± 4.8 0.8
TUR-P/TUR-B 15 (75)/5 (25) 14 (70)/6 (30) 14 (70)/6 (30) 0.8
*Data presented as mean ± standard deviation, n or n (%). Groups = Spinal anesthesia group; Group L = low dose spinal anesthesia
group; Group E = epidural anesthesia group; ASA = American Society of Anesthesiologists risk class; TUR-P = transurethral resection
of prostate procedure; TUR-B = transurethral resection of bladder tumors procedure.
Table 2. Characteristics of regional anesthesia techniques*
Group S (n = 20) Group L (n = 20) Group E (n = 20) p
Sensory block
Onset time of T10 level block (min) 5.7 ± 1.3†§ 12.0 ± 2.9†‡ 25.1 ± 6.5‡§ 0.001
Time to reach maximum sensory level (min) 8.0 ± 1.4†§ 11.9 ± 5.2†‡ 25.9 ± 5.7‡§ 0.001
Time to two-segment regression (min) 91.0 ± 8.2†§ 79.5 ± 7.9†‡ 124.0 ± 5.9‡§ 0.001
Time to full recovery (min) 182.8 ± 15.1† 125.0 ± 9.3†‡ 187.8 ± 7.7‡ 0.001
Motor block 0.001
BS 0 0 9 (45) 7 (35)
BS 1 0 4 (20) 3 (15)
BS 2 1 (5) 4 (20) 3 (15)
BS 3 19 (95) 3 (15) 7 (35)
Time to full recovery (min) 157.0 ± 9.8† 97.1 ± 21.9†‡ 138.3 ± 18.9‡ 0.001
Adverse events
Nausea 6 (30) 0 0 0.001
Vomiting 0 0 0 NS
Itching 4 (20) 0 0 NS
Local anesthetic toxicity 0 0 0 NS
Ephedrine usage 5 (25) 0 0 0.004
PDPH 3 (15) 3 (15) 0 0.189
Patient comfort NS
Very good 13 (65) 16 (80) 17 (85)
Good 7 (35) 4 (20) 3 (15)
*Data presented as mean ± standard deviation, n or n (%); †p < 0.05 between Group S and Group L; ‡p < 0.05 between Group E and
Group L; §p < 0.05 between Group S and Group E; 0: no motor block, 1: partial motor blockade, 2: almost complete motor blockade,
3: complete motor blockade. BS = Bromage scale; PDPH = post dural puncture headache; Group S = spinal anesthesia group; Group
L = low dose spinal anesthesia group; Group E = epidural anesthesia group; NS = not significant.
There were significant differences in the frequency
of motor block between Groups S and E, Groups E and
L, and Groups S and L (all: p < 0.001; Table 2). How-
ever, there were no differences in the visual analog
scale scores between any groups (p > 0.05). Additional
analgesic agents were not needed in any group.
Similarly, RR and SpO2 were comparable in all three
groups.
Intraoperative and postoperative
hemodynamic changes
There were no significant difference in mean arterial
BPs and changes in HRs between the three groups
(Figures 2 and 3).
Complications and patient comfort
Nausea was observed in six patients (30%) in Group S
versus none in Groups E and L (p < 0.005). Vomiting
was not observed in any of the three groups. Only four
patients in Group S experienced itching versus none in
Groups L and E. Unilateral block and local anesthetic
agent toxicity did not occur in any patients of the all
group. Ephedrine was used in five patients in Group S
versus none in Groups L and E (p < 0.05). There were
no differences between groups in terms of post dural
puncture headache and patient comfort (Table 2).
Power analysis
Sensory block end times, two-segment regression
times, and full recovery of motor block times were con-
sidered in the power analysis. The α error was defined
as 0.05. Thus, the power of the study was > 98% [9].
DISCUSSION
It has been reported that hyperbaric ropivacaine pro-
vides significantly shorter motor block duration, faster
regression of sensory block, and faster mobilization
than an equivalent dose of hyperbaric bupivacaine
and levobupivacaine [8]. Luck et al also reported that
hyperbaric ropivacaine may be preferred because of its
shorter motor block and duration of effect, particularly
for patients requiring fast mobilization. Casati et al [10]
concluded that levobupivacaine or ropivacaine may be
used as alternatives to bupivacaine in spinal anesthesia.
In the study by Malinovsky et al [11], patients un-
dergoing TUR-P or transurethral resection of bladder
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Figure 1. Changes in sensory block over time. S=Spinal anesthesia;
L= low-dose spinal anesthesia; E= epidural anesthesia; T= thoracic.
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Figure 2. Changes in mean blood pressure over time. S = Spinal
anesthesia; L= low-dose spinal anesthesia; E= epidural anesthesia;
T= thoracic.
Time (min)
1 3 5 10 15 20 25 30 40 50 60 90 12
0
15
0
18
0
21
0
24
0
65
70
75
80
85
B
ea
ts
/
m
in
Group S Group LGroup E
Figure 3. Changes in heart rate over time. S=Spinal anesthesia;
L= low-dose spinal anesthesia; E = epidural anesthesia.
tumors were intrathecally administered with 15 mg
ropivacaine and the results seemed to suggest the
motor and hemodynamic effects were similar to 10 mg
bupivacaine. In another study, the 50% effective dose
of hyperbaric ropivacaine in spinal anesthesia for
cesarean section was 10.37 mg and the 95% effective
dose was 15.39 mg [12]. In our study, we used 15 mg
of hyperbaric ropivacaine in Group S and 10 mg in
Group L.
Fettes et al [13] compared the plain and hyperbaric
formulations of ropivacaine for spinal anesthesia. They
concluded that the block starting time and block re-
gression speed were both greater for hyperbaric rop-
ivacaine, which is prepared by adding glucose to
ropivacaine. The authors emphasized that, in surgery
above the L1 dermatome, plain solutions were less
safe. Kallio et al [14] also reported that motor and sen-
sory block regression times and the duration of hos-
pital stay were shorter with spinal anesthesia induced
by 15 mg hyperbaric ropivacaine than with plain ropi-
vacaine for lower extremity surgery. Thus, the results
in our study are consistent with the above findings,
and we obtained earlier mobilization with the use of
hyperbaric ropivacaine solutions for spinal anesthesia.
Combining fentanyl with bupivacaine has been re-
ported to increase the quality of spinal anesthesia, and
enhance anesthesia without extending sensory or mo-
tor recovery times or length of hospital stay [15]. In 
a study comparing the intrathecal administration of
10 mg of hyperbaric ropivacaine with 7.5 mg of hyper-
baric bupivacaine in patients undergoing TUR-P, no
significant difference was found between the groups
for the time to reach the T10 dermatomal level. Motor
block time was 57 minutes in the ropivacaine group
versus 82.4 minutes in the bupivacaine group. The
sensory block regression time was 86.5 minutes with
ropivacaine versus 92.5 minutes with bupivacaine. 
It was subsequently reported that different doses of
ropivacaine may be needed relative to bupivacaine in
TUR-P patients because it causes shorter motor block
times [16]. Our results agree with these earlier studies.
We obtained a shorter motor block and a longer anal-
gesia time for spinal anesthesia by combining 10 mg
of hyperbaric ropivacaine with 25 μg of fentanyl.
Kallio et al [17] compared intrathecal administra-
tion of 10 mg of hyperbaric ropivacaine plus 20 μg of
fentanyl versus 15 mg of hyperbaric ropivacaine. They
concluded that the group given 10 mg of hyperbaric
ropivacaine displayed earlier mobilization, but there
were no differences in terms of time to onset and
duration of analgesia. Another study compared the
effectiveness of 10 mg of hyperbaric ropivacaine in
combination with 5 μg of sufentanil versus 15 mg of
hyperbaric ropivacaine alone for spinal anesthesia in
patients undergoing cesarean section [18]. The com-
bination was observed to cause significantly less hypo-
tension, nausea, shivering, shortened motor block
time, and longer analgesia than 15 mg of ropivacaine.
In a study comparing the combinations of ropiva-
caine plus fentanyl and bupivacaine plus fentanyl for
spinal anesthesia in transurethral procedures, Lee et al
[19] used isobaric solutions and the sensory block level
was similar in both groups, while the motor block
time was shorter with ropivacaine plus fentanyl and
all patients displayed full motor block. In our study,
we found that hyperbaric ropivacaine plus fentanyl
elicited short-term motor block; and full motor block
did not even occur in some patients in the low-dose
spinal group. The results obtained in Group L are
consistent with those obtained by Kallio et al [17] in
patients given a combination of 10 mg of hyperbaric
ropivacaine plus 20 μg of fentanyl for spinal anesthe-
sia in day surgeries.
Previous studies have emphasized the importance
of the concentration of ropivacaine. In a study com-
paring the epidural administration of 20 mL of 0.75%
ropivacaine versus 100 μg of fentanyl in combination
with 0.5% bupivacaine in patients undergoing elec-
tive cesarean section, there were no differences in
sensory block time, or the time to reach the T4 and S1
levels between the two groups. However, ropivacaine
elicited deeper and longer motor block. The authors
reported that 0.75% ropivacaine used epidurally with-
out opioids may offer an alternative to 0.5% bupiva-
caine in combination with fentanyl [20]. Similar to
our study, Cederholm et al [21] reported that 20 mL of
ropivacaine given epidurally at a concentration of 0.5%
or 0.75% with and without epinephrine. They stated
that although 0.75% ropivacaine solution provided
more rapid onset of analgesia and longer duration of
sensory block than 0.5% ropivacanine solution, they
both provided adequate sensory level and motor block
in transurethral surgery. They also concluded that the
addition of epinephrine did not significantly prolong
sensory or motor block, or affect sympathetic block.
In our study, more rapid onset, adequate and effective
sensory block, and faster recovery were observed with
epidural and low-dose spinal anesthesia. The mean
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time to reach the maximum sensory level was 8 min-
utes in Group S, 26 minutes in Group E and 12 min-
utes in Group L. The T10 dermatome level was
reached most quickly in Group S and most slowly in
Group E. However, the motor block emergence rates
were 95% in Group S (19 patients), 35% in Group L
(7 patients), and 15% in Group E (3 patients).
All of our groups experienced adequate anesthesia,
recovery and early mobilization after the transurethral
procedures. We believe that the higher dose adminis-
tered may be responsible for the longer duration of
analgesia, the shorter time to reach maximum sensory
level, and the more frequent motor block development
in the Group S (15 mg of hyperbaric ropivacaine, in-
trathecal) than in Group L (10 mg of hyperbaric ropi-
vacaine). There was a significant difference in the time
to reach maximum motor block and two-segment
block regression, and the time to full recovery of mo-
tor block. The two-segment regression time was sig-
nificantly longer in Group E than in the other groups.
We believe that the epidural anesthesia method used
can affect the duration of anesthesia due to anatomi-
cal and physiological changes, particularly in elderly
patients, as permeability of and sensitivity to local
anesthetics increase with age.
Hypotension is a frequent adverse effect that oc-
curs in approximately 30% of patients during spinal
anesthesia [22]. The nerve block (T6–L1) causes ac-
cumulation of blood in the capacitance veins in the
splanchnic bed, which contributes to the development
of hypotension induced by high levels of anesthesia.
Other factors triggering this include a reduction in
cardiac reserve with increasing age, structural changes
in arterioles, and changes in the autonomous nervous
system [23]. No clinically significant changes occurred
in any of our patients in terms of HR, BP, RR and
SpO2. However, some patients in Group S displayed
a slight decrease in mean arterial BP, meaning that
when 5 mg of ephedrine was administered in five
patients, positive responses were achieved in all five
patients. We believe that the slight fall in BP may have
been due to decreased peripheral vascular resistance
because spinal anesthesia causes faster onset of sym-
pathetic block than epidural anesthesia. Previous stud-
ies have also shown that low-dose bupivacaine alone
or in combination with low doses of fentanyl dramat-
ically reduces the risk of hypotension [24]. In our study,
we believe that the lower dose of ropivacaine used in
Group L was responsible for the absence of ephedrine
administration in that group compared with that in
Group S.
Although no significant difference was observed
in any of the three groups in terms of HR, a slight de-
crease was seen in Groups S and E during the first 
15 minutes. We believe that the changes in HR and
systolic BP during the early phase of the surgery can
be explained by the doses of anesthetics and the anes-
thesia method applied.
The hemodynamic data for Group E are not con-
sistent with those reported by Wolff et al [25], who
reported frequent bradycardia and hypotension after
administration of 20 mL of 0.75% or 20 mL of 1% ropi-
vacaine for lumbar epidural anesthesia in elderly pa-
tients undergoing hip surgery. We attribute this to the
lower dose used in our study. In a study comparing
the use of administration of 7.5 mg/mL hyperbaric
ropivacaine and 7.5 mg/mL hyperbaric levobupiva-
caine for spinal anesthesia for knee arthroscopy, ropi-
vacaine was associated with less frequent hypotension
and bradycardia [26].
We suggest that the lack of hemodynamic changes
could have occurred due to intravascular absorption
of the irrigation solution into the bladder after start-
ing surgery in our study because the operation time
was not extended in any group.
After sensory block disappeared, additional anal-
gesics were not required in any group. This could be
because the patients experienced considerably less
pain during endoscopic transurethral procedures than
during open surgeries.
Intrathecal lipophilic opioids may exert adverse
effects such as nausea, vomiting, urinary retention,
itching, and dose-dependent respiratory depression.
However, even in elderly patients, intrathecal admin-
istration of 25 μg of fentanyl has been shown to pro-
vide effective preoperative analgesia without causing
respiratory depression [27]. In a study using intrathe-
cal administration of hyperbaric ropivacaine plus fen-
tanyl for TUR-P, patients given 18 mg of hyperbaric
ropivacaine plus 25 μg of fentanyl did not experience
any nausea or vomiting [16]. In our study, only six pa-
tients in Group S reported nausea, although this may
be related to the slight fall in mean arterial BP.
Itching was reported by four patients in Group S as
well. However, this was of short duration and weak
intensity, and did not require medication. Nausea,
vomiting, and itching were not reported by patients
in the other groups. Local anesthetic toxicity, postural
Regional anesthesia for TUR with ropivacaine
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headache, and temporary neurological symptoms
were not reported in any group.
In conclusion, an adequate sensory level can be
reached without episodes of serious hypotension using
ropivacaine in combination with fentanyl. Epidural
administration of 15mL of plain ropivacaine plus 25 μg
of fentanyl was associated with less motor block than
the other groups. Adequate operative anesthesia with-
out any major side effects can be elicited with low-
dose intrathecal administration of 10 mg of hyperbaric
ropivacaine in combination with 25 μg of fentanyl.
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